ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AM Best Revises Outlooks to Negative for Heartland National Life Insurance Company

AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Heartland National Life Insurance Company (HNL) (Indianapolis, IN).

The Credit Ratings (ratings) reflect HNL’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limited business profile and marginal enterprise risk management (ERM).

The revised outlooks reflect downward pressure on the company’s overall balance sheet strength assessment due to significant annuity growth that has outpaced excess risk-adjusted capitalization, which has been supported by high third-party reinsurance dependence. AM Best notes that HNL has signed an indicative term sheet with a third-party investment group, which may acquire a minority stake in HNL, by making equity contributions that would significantly enhance its absolute and risk-adjusted capital levels. The overall amount of capital contributions also depends on HNL selling or reinsuring part of its supplemental accident and health (A&H) insurance block to another strategic partner, which would unlock additional capital, enhance near-term earnings under management’s projections through a favorable ceding commission(s) and diversify HNL’s reinsurance counterparties. A negative rating action could occur if HNL fails to improve its risk-adjusted capitalization by executing further on its aforementioned capital raise plans that include either equity or debt investment or additional reinsurance.

Following a year of extensive individual deferred fixed annuity sales targeted to the savings and retirement needs of policyowners, HNL's business profile now has more long-duration asset-liability matching and interest rate risk, in addition to biometric risk from a core portfolio of profitable supplemental A&H business. The latter product line is considered lower risk for insurers on AM Best’s product continuum primarily attributed to providing cash benefits, rather than full medical cost reimbursement, to address policyowners’ health insurance coverage gaps.

HNL has traditionally used extensive reinsurance to share risk and manage capital strain as it executes its growth initiatives under its strategic plan and evolving ERM framework; and in October 2023, the company implemented a 95% quota share flow reinsurance agreement for the annuity sales with Puerto Rico-based Converge Re II. In December 2024, a $7 million surplus note was also issued by HNL, and HNL has access to another $8 million of backup liquidity it can draw from the same credit facility if needed. Altogether these initiatives have helped HNL manage the capital strain associated with its rapid growth; however, this is partially offset by high reinsurance leverage associated with the annuity business that has increased reinsurance counterparty risk capital charges and operational risk. In addition, HNL has reported statutory net losses in 2025, owing to continued high general expenses and direct commissions associated with its high volume of sales and new product launches, which included short-term home health care and cancer heart attack and stroke insurance in 2023 and 2024 respectively, and the upcoming launch of a new fixed index annuity product in some of the company’s 36 approved states. HNL’s relatively small amount of capital and surplus, as compared with its gross liabilities and its various competitors that also focus on the annuity market for the senior demographic, places pressure on the company’s reliance on its sole annuity reinsurer, Converge Re II. Additionally, AM Best notes the elevated financial leverage and modest coverage ratios, as well as the execution risk related to HNL enhancing its capital position given the company’s concentrated capital structure.

AM Best will continue to monitor the company's capitalization and operating performance over the next few quarters against its planned capital management initiatives and current business plan, along with the mix of business between annuity and A&H insurance.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.56
+0.00 (0.00%)
AAPL  274.61
+0.00 (0.00%)
AMD  209.17
+0.00 (0.00%)
BAC  54.81
+0.00 (0.00%)
GOOG  307.73
+0.00 (0.00%)
META  657.15
+0.00 (0.00%)
MSFT  476.39
+0.00 (0.00%)
NVDA  177.72
+0.00 (0.00%)
ORCL  188.65
+0.00 (0.00%)
TSLA  489.88
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.